MONTE ROSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FOR MRT-8102 IN GFORCE-1 PHASE 1 STUDY SHOWING NORMALIZATION OF KEY PATHOGENIC DRIVERS OF ASCVD IN SUBJECTS WITH ELEVATED CVD RISK

Reuters · 3d ago

Please log in to view news